SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : FPA Medical Management - FPAMQ -- Ignore unavailable to you. Want to Upgrade?

To: Douglas V. Fant who wrote (802)6/29/1998 11:55:00 PM
From: Tom Hua  Respond to of 1110
 
But correct me if I am wrong but FPAM will need to drive its stock price back above
$4/share in order to remian listed on the NASDAQ unless the NASDAQ waives that
requirement

Doug, there're plenty of NASDAQ stocks under $4. In fact, some are under $1. I don't remember the listing requirements (assets, market cap, prompt filings of SEC documents etc..), but stock price alone is not the determining factor.

Regards,

Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News